Executive War College 2026: 6 Takeaways Diagnostics Leaders Cannot Afford to Ignore

The 31st Annual Executive War College on Diagnostics, Clinical Laboratory, and Pathology Management brought diagnostics, pathology, and laboratory leaders together at a moment when financial, operational, and administrative pressures continue to intensify across healthcare. But while many of the challenges discussed at this year’s event were familiar (rising denials, growing documentation requirements, staffing strain, and reimbursement uncertainty) the tone of the conversations felt notably different.

Compared with prior years, there was far less discussion centered around on what’s causing disruption and more focus on execution. Across sessions and hallway conversations alike, leaders were increasingly focused on how to operationalize change inside revenue cycle and reimbursement workflows already under significant pressure.

A recurring theme throughout the conference was the growing belief that payors are institutionalizing friction through more variable policies, automated review practices, and escalating administrative demands. In response, many organizations are reevaluating how work gets done across the full reimbursement lifecycle—from intake and eligibility through denials, appeals, patient engagement, and financial analytics.

Artificial intelligence was central to many of those discussions, though the conversation has clearly evolved. The focus is shifting away from broad AI experimentation and toward practical operational use cases designed to reduce administrative burden, improve financial performance, and help teams scale without simply adding headcount.

Below are six of the most important themes and takeaways that emerged from Executive War College 2026.

1. Payors Are Institutionalizing Friction

Diagnostic organizations continue to face changing coverage policies, growing documentation expectations, rising denial volumes, and increasingly automated payor review practices. More broadly, many organizations described a growing sense that payors are institutionalizing friction through more variable policies, automated edits, and escalating administrative requirements that increase provider burden and slow reimbursement.

Several discussions reflected growing concern around how rapidly administrative complexity is compounding. Payor scrutiny continues to increase, while reimbursement workflows are becoming more difficult to navigate and more resource-intensive to manage.

As a result, many attendees acknowledged that traditional revenue cycle approaches built around manual review and downstream rework are increasingly becoming unsustainable. The conversation is shifting from how organizations react to friction toward how they operationalize earlier intervention, greater automation, and more coordinated workflows to reduce it.

2. AI Is Moving from Talk to Tactics

Artificial intelligence remained one of the dominant topics throughout Executive War College 2026, though the conversation felt more grounded than in years past.

The focus was less on future possibilities and more on practical applications within revenue cycle operations. Across sessions and hallway discussions alike, there was growing interest in how AI has already helped reduce the administrative burden and where else it can be applied to improve operational performance.

Areas receiving the most attention included:

• Prior authorization
• Denial management
• Appeals processing
• Documentation review
• Patient responsibility estimation
• Interpretation of payor responses and policy changes

There also seemed to be broader recognition that AI is not a standalone strategy. Its value depends largely on how effectively it aligns with operational processes, is supported by reliable information, and addresses specific business problems.

For many diagnostics leaders, the conversation is becoming increasingly practical: where can automation reduce friction, improve consistency, and allow teams to manage increasing administrative demands without simply adding headcount? AI is increasingly being viewed less as a future initiative and more as operational infrastructure.

3. Revenue Cycle Strategy Conversations Are Expanding Beyond Billing

Another recurring theme was the recognition that financial outcomes are shaped long before a claim is submitted.

Many discussions focused on how disconnected processes across the revenue cycle continue to create avoidable friction. Even relatively minor breakdowns in intake, eligibility verification, documentation, or patient communication can lead to downstream reimbursement issues that become costly to resolve later.

The conversation has become much broader than billing alone. Leaders are increasingly evaluating how information and decision-making flow across the full reimbursement lifecycle, including:

• Front-end patient and order intake
• Provider engagement
• Coverage verification
• Claim submission
• Denial prevention and appeals
• Payment posting
• Financial reporting and analytics

There was also growing acknowledgment that siloed operational models are becoming harder to maintain as staffing pressures and administrative demands continue to increase.

4. Denials and Appeals Are Becoming Strategic Financial Functions

Several discussions reflected a broader shift toward earlier intervention and risk identification. Rather than reacting after denials occur, revenue cycle leaders are increasingly looking for ways to identify vulnerabilities sooner, intervene earlier, and prepare more precise responses before reimbursement delays escalate.

Common priorities discussed included:

• Earlier identification of reimbursement risk
• Better visibility into denial trends
• Prioritization of recoverable revenue
• Reduction of preventable leakage
• Faster response to changing payor behavior

Another subtle but important shift: denial prevention and appeals management are no longer viewed as isolated back-office functions. Increasingly, they are being treated as integral financial disciplines within revenue cycle operations, directly impacting operating margin, cash flow predictability, and long-term sustainability.

The operational question is no longer simply how to process denials faster, but how to manage reimbursement risk more strategically across the entire organization.

5. Patient Financial Responsibility Is Moving Upstream

Patient affordability and payment behavior were also recurring topics throughout the event.

As out-of-pocket costs continue to rise, many organizations are rethinking how and when they engage patients financially. Historically, patient billing often occurred near the end of the revenue cycle process. That approach is becoming less effective.

Across discussions, there was increased focus on providing earlier financial clarity and reducing friction for patients before testing occurs.

Areas receiving the most attention included:

• More accurate cost estimates
• Clearer patient communication
• Expanded digital payment options
• Automated payment reminders
• More consumer-friendly billing experiences

The broader industry shift is becoming difficult to ignore: patient financial engagement is increasingly being treated as part of the front-end experience rather than a downstream collections function.

6. Transparency and Analytics Are Reshaping Financial Strategy

Market transparency and financial analytics were also major areas of discussion throughout Executive War College 2026.

As contracted rate and reimbursement information becomes more accessible, diagnostic organizations are gaining broader visibility into market variation, payor behavior, and operational trends. The challenge now is less about obtaining information and more about using it effectively.

Many of the questions raised during the conference centered around practical financial decision-making:

• Where are reimbursement trends deteriorating?
• How do contracted rates compare across markets and payors?
• Which payors are creating the greatest operational burden?
• Where are denials increasing most rapidly?
• Which operational changes could materially improve financial outcomes?

The emphasis appears to be shifting toward more evidence-based decision-making, particularly around contracting strategy, denial prevention, and operational prioritization.

At the same time, advocacy and industry collaboration remain critical. Ongoing uncertainty surrounding reimbursement policy, regulatory oversight, and federal healthcare initiatives continues to create concern across the diagnostics industry. A recurring point raised in several discussions was that no single organization will be able to address these pressures independently.

Industry collaboration remains essential—particularly among laboratories, pathology groups, professional associations, healthcare leaders, and policy advocates working to preserve access to diagnostic testing while helping shape future reimbursement and regulatory frameworks.

The Next Phase of Revenue Cycle Is Taking Shape

The broader message emerging from Executive War College 2026 was clear: diagnostics organizations are moving beyond discussion and into execution—reassessing how revenue cycle operations, analytics, automation, and financial strategy must evolve together to operate more effectively in an increasingly complex reimbursement environment.

Interested in learning how diagnostics organizations are already tackling these War College themes using XiFin Empower AI to improve reimbursement operations and reduce administrative burden? Contact us to learn more or schedule a demonstration of the new Empower AI Appeals Agent.